Our Collaborators

Theranostics Trial Center

Affibody collaborates with Theranostics Trial Center (TTC), which is a newly established highly specialized research center that gathers excellence in target-directed treatments, primarily in cancer. The center is a joint venture of Karolinska University Hospital and Karolinska Institutet. It is also the first Theranostics Trial Center in Sweden and the Nordics. TTC focuses on early-phase clinical trials of radiolabeled targeted drugs for diagnosing and treating cancer patients.

Uppsala University

Affibody has a long-standing collaboration with Professor Tolmachev’s research group at Uppsala University. Professor Tolmachev is an internationally prominent expert in radiopharmaceuticals.